Nanopharm-logo-with-signature-Pantone (1)
Search
Close this search box.

Nanopharm Newsletter November 2024

Blue gradient background with a small letter I in a circle in the background with white News & Events text.

Nanopharm is leading innovation in OINDP, inhalation, and nasal drug delivery with FDA collaboration and advanced spray-drying technology.

Interview with Jane Provis Evans, Head cGMP services at Nanopharm

In the ever-evolving world of pharmaceuticals, the importance of stringent quality control cannot be overstated. This interview with Jane Provis-Evans, Head of cGMP Analysis at Nanopharm, sheds light on the critical role of cGMP testing in the development and optimization of drug-device combinations, particularly for orally inhaled and nasal drug products (OINDPs). With the launch of Nanopharm’s new GMP services, the company is well-positioned to help clients bring innovative treatments to patients.